Provider: Nature Publishing Group
Content: application/x-research-info-systems
TY  - JOUR

AU  - Economides, A.N.

TI  - Cytokine traps: Multi-component, high-affinity blockers of cytokine action

JO  - Nature Med.

PY  - 2003///

VL  - 9

SP  - 47

EP  - 52

M3  - 10.1038/nm811

N1  - 10.1038/nm811

UR  - http://dx.doi.org/10.1038/nm811

ER  - 



TY  - JOUR

AU  - Stahl, N.

AU  - Yancopoulos, G.D.

TI  - The alphas, betas, and kinases of cytokine receptor complexes

JO  - Cell

PY  - 1993///

VL  - 74

SP  - 587

EP  - 590

M3  - 10.1016/0092-8674(93)90506-L

N1  - 10.1016/0092-8674(93)90506-L

UR  - http://dx.doi.org/10.1016/0092-8674(93)90506-L

ER  - 



TY  - JOUR

AU  - Frishman, J.I.

TI  - Tumor necrosis factor (TNF)-[alpha]-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors

JO  - J. Infect. Dis.

PY  - 2000///

VL  - 182

SP  - 1722

EP  - 1730

M3  - 10.1086/317605

N1  - 10.1086/317605

UR  - http://dx.doi.org/10.1086/317605

ER  - 



TY  - JOUR

AU  - Preas, H.L.

TI  - Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxin

JO  - Blood

PY  - 1996///

VL  - 88

SP  - 2465

EP  - 2472

ER  - 



TY  - JOUR

AU  - Moreland, L.W.

TI  - Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

JO  - N. Engl. J. Med.

PY  - 1997///

VL  - 337

SP  - 141

EP  - 147

M3  - 10.1056/NEJM199707173370301

N1  - 10.1056/NEJM199707173370301

UR  - http://dx.doi.org/10.1056/NEJM199707173370301

ER  - 



TY  - JOUR

AU  - Fleischman, R.

TI  - A safety trial of anakinra: Recombinant interleukin-1 receptor antagonist in a large, placebo controlled heterogenous population of patients with rheumatoid arthritis

JO  - Arthrit. Rheumat.

PY  - ///

SP  - 

EP  - 

ER  - 



TY  - JOUR

AU  - Bresnihan, B.

TI  - Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist

JO  - Arthrit. Rheum.

PY  - 1998///

VL  - 41

SP  - 2196

EP  - 2204

M3  - 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2

N1  - 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2

UR  - http://dx.doi.org/10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2

ER  - 



TY  - JOUR

AU  - Keane, J.

TI  - Tuberculosis associated with infliximab, a tumor necrosis factor-[alpha]-neutralizing agent

JO  - N. Engl. J. Med.

PY  - 2001///

VL  - 345

SP  - 1098

EP  - 1104

M3  - 10.1056/NEJMOA011110

N1  - 10.1056/NEJMOA011110

UR  - http://dx.doi.org/10.1056/NEJMOA011110

ER  -